Gritstone Bio Inc

NASDAQ:GRTS   3:59:55 PM EDT
11.52
+0.17 (+1.50%)
Products

Gritstone And CEPI Announce Agreement To Advance COVID-19 Vaccine Program

Published: 08/17/2021 11:23 GMT
Gritstone Bio Inc (GRTS) - Gritstone and Cepi Announce Agreement to Advance Second-generation Covid-19 Vaccine Program (coral) Against Sars-cov-2 Variants of Concern.
Gritstone Oncology - Cepi to Fund Co's Work on 2nd-gen Vaccines Against Sars-cov-2, Including Clinical Trial in South Africa & Manufacturing Optimization.
Gritstone Oncology Inc - Co Entered Into a Funding Agreement of Up to $20.6 Million With Cepi.
Gritstone Oncology Inc - Cepi Will Fund a Multi-arm Phase 1 Study Evaluating Coral Program's Sam Vaccine in NaÏve, Convalescent, and Hiv+ Patients.
Gritstone Oncology - Multi-arm Phase 1 Study Expected to Initiate Before End of 2021.